Legal & General Group PLC Acadia Pharmaceuticals Inc Call Options Transaction History
Legal & General Group PLC
- $423 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ACAD
# of Institutions
298Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$700 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$226 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$217 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$190 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$97.9 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.64B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...